ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0JGL Pci Biotech Holding Asa

51.00
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Pci Biotech Holding Asa LSE:0JGL London Ordinary Share NO0010405640 PCI BIOTECH HOLDING ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 51.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.99M -20.32M -0.5443 -93.70 1.9B

Disclosure of voting rights for Chair of the Board

23/05/2024 8:03am

UK Regulatory


Pci Biotech Holding Asa (LSE:0JGL)
Historical Stock Chart


From Jun 2024 to Jun 2024

Click Here for more Pci Biotech Holding Asa Charts.
Disclosure of voting rights for Chair of the Board

Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors.

Hans Peter Bøhn is chair of PCI Biotech’s board of directors and shall open the annual general meeting of the Company on 24 May 2024. Mr. Bøhn holds 123,662 shares, representing 0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 4,288,185 additional shares. In total, Mr. Bøhn will represent and vote for 11.8 percent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 24 May 2024.

This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12 of the Norwegian Securities Trading Act.

Contact information:    
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo        
Ronny Skuggedal, CEO/CFO, rs@pcibiotech.no, Mobile: +47 9400 5757


1 Year Pci Biotech Holding Asa Chart

1 Year Pci Biotech Holding Asa Chart

1 Month Pci Biotech Holding Asa Chart

1 Month Pci Biotech Holding Asa Chart

Your Recent History

Delayed Upgrade Clock